[HTML][HTML] The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges
Medical imaging can assess the tumor and its environment in their entirety, which makes it
suitable for monitoring the temporal and spatial characteristics of the tumor. Progress in …
suitable for monitoring the temporal and spatial characteristics of the tumor. Progress in …
Machine and deep learning methods for radiomics
Radiomics is an emerging area in quantitative image analysis that aims to relate large‐scale
extracted imaging information to clinical and biological endpoints. The development of …
extracted imaging information to clinical and biological endpoints. The development of …
Machine learning applications in prostate cancer magnetic resonance imaging
R Cuocolo, MB Cipullo, A Stanzione, L Ugga… - European radiology …, 2019 - Springer
With this review, we aimed to provide a synopsis of recently proposed applications of
machine learning (ML) in radiology focusing on prostate magnetic resonance imaging (MRI) …
machine learning (ML) in radiology focusing on prostate magnetic resonance imaging (MRI) …
[HTML][HTML] Reliability of serial prostate magnetic resonance imaging to detect prostate cancer progression during active surveillance: a systematic review and meta …
Context Although magnetic resonance imaging (MRI) is broadly implemented into active
surveillance (AS) protocols, data on the reliability of serial MRI in order to help guide follow …
surveillance (AS) protocols, data on the reliability of serial MRI in order to help guide follow …
Machine learning in prostate MRI for prostate cancer: current status and future opportunities
Advances in our understanding of the role of magnetic resonance imaging (MRI) for the
detection of prostate cancer have enabled its integration into clinical routines in the past two …
detection of prostate cancer have enabled its integration into clinical routines in the past two …
An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of …
Summary Background Biparametric MRI (comprising T2-weighted MRI and apparent
diffusion coefficient maps) is increasingly being used to characterise prostate cancer …
diffusion coefficient maps) is increasingly being used to characterise prostate cancer …
Current status of artificial intelligence applications in urology and their potential to influence clinical practice
Objective To investigate the applications of artificial intelligence (AI) in diagnosis, treatment
and outcome predictionin urologic diseases and evaluate its advantages over traditional …
and outcome predictionin urologic diseases and evaluate its advantages over traditional …
Prostate MRI radiomics: a systematic review and radiomic quality score assessment
A Stanzione, M Gambardella, R Cuocolo… - European journal of …, 2020 - Elsevier
Background Radiomics have the potential to further increase the value of MRI in prostate
cancer management. However, implementation in clinical practice is still far and concerns …
cancer management. However, implementation in clinical practice is still far and concerns …
Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI
Objectives To develop an automatic method for identification and segmentation of clinically
significant prostate cancer in low-risk patients and to evaluate the performance in a routine …
significant prostate cancer in low-risk patients and to evaluate the performance in a routine …
[HTML][HTML] Multi-parametric MRI-based radiomics signature for discriminating between clinically significant and insignificant prostate cancer: Cross-validation of a …
X Min, M Li, D Dong, Z Feng, P Zhang, Z Ke… - European journal of …, 2019 - Elsevier
Purpose To evaluate the performance of a multi-parametric MRI (mp-MRI)-based radiomics
signature for discriminating between clinically significant prostate cancer (csPCa) and …
signature for discriminating between clinically significant prostate cancer (csPCa) and …